Figure 1.
Predicted LS mean NIS‐LL change from baseline to month 12 across a range of baseline NIS‐LL values in the intent‐to‐treat placebo and tafamidis cohorts. NIS‐LL, Neuropathy Impairment Score – Lower Limbs.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.